Meningococcal Disease Completed Phase 4 Trials for Meningococcal (groups A, C, Y and W-135) oligosaccharide diphtheria CRM197 conjugate vaccine (DB10061)

IndicationStatusPhase
DBCOND0033309 (Meningococcal Disease)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01593514Understanding the Immune Response to Two Different Meningitis VaccinesBasic Science